Neuren Pharmaceuticals

Drugs for brain injury and neurodegenerative disorders.

placeMelbourne, Victoria, Australia calendar_todayFounded 1993 groups15 employees language neurenpharma.com

Registered entities

Innovation

45 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,722 times.

YearFilings
20147
20156
20164
20174
20182
20202
20215
20224
20235
20243
20255
20262

Social engagement

Social engagement: 3.4K social following, 8 posts in the last 12 months — above the industry median.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%

Recent activity

16 Jun 2026
Event
Macquarie Mid-Cap Conference
9 Jun 2026
Event
Morgan Stanley 8th Australia Summit
27 May 2026
Event
AGM Chair Address & CEO Presentation
Coming soon